在2024年11月8日盘前交易中,ANI Pharmaceuticals(股票代码:ANIP)股价大涨8.77%,引发市场广泛关注。导致该公司股价大涨的主要原因是其第三季度财报数据超出华尔街分析师预期。
具体来看,ANI制药在截至2024年9月30日的第三季度公布了亮眼的财务业绩。该公司调整后每股收益达到1.34美元,高于分析师平均预期的1.09美元。营收方面,ANI公司季度营收为1.4833亿美元,同比增长12.5%,也超出了分析师预期的1.4435亿美元。
ANI制药优异的季度业绩受到了分析师界的积极评价。目前分析师对该公司股票的一致评级为"买入",其中多数分析师给予了"强烈买入"或"买入"等积极评级,华尔街预计该股未来12个月的中位目标价为83美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.